Skip to Main Content

Paper Details

Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan.
Glycoconj J
10
2010
(wt) p53 gene, -treated cells, GD1, U87, U87 MG glioblastoma cells, glioma, human, human glioma cell line U87, irinotecan, mRNA, murine, p53 gene, phosphatidyl ethanolamines, phosphatidyl glycerols, phosphatidyl inositols, phosphatidyl serines, topoisomerase-1, wild type p53, wild-type, wild-type (wt) p53 gene, wild-type p53, wild-type p53-treated cells

Datasets

Release 1.2